Petrovax Pharm started shipping Grippol® plus vaccine for influenza prevention in children within the framework of the Russian National Immunization Schedule (RNIS). Through the end of October, all Russia’s regions will receive more than 8.5 m Grippol® plus doses.
In 2016, the children population is being covered with flu vaccine Grippol® plus within the RNIS framework under the agreement with National Immunobiological Company OJSC that has been appointed the sole vendor pursuant to the Russian Government Resolution No.
Petrovax Pharm is the Russian largest vaccine manufacturer, with more than 20 m doses of flu vaccine, and more than 4.5 m doses of pneumococcal vaccine a year.
Vaccine background information
Grippol® plus is the only Russian subunit adjuvanted inactivated influenza vaccine with high efficacy and safety than have been proved by
Every year, the vaccine formula is updated pursuant to the WHO guidelines for a specific epidemic season. Grippol® plus is produced from local ingredients only, including antigens.